147 related articles for article (PubMed ID: 38558635)
21. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
22. Female gender as independent risk factor of torsades de pointes during acquired atrioventricular block.
Chorin E; Hochstadt A; Viskin S; Rozovski U; Havakuk O; Baranchuk A; Enriquez A; Strasberg B; Guevara-Valdivia ME; Márquez MF; González-Pacheco H; Hasdemir C; Rosso R
Heart Rhythm; 2017 Jan; 14(1):90-95. PubMed ID: 27650425
[TBL] [Abstract][Full Text] [Related]
23. Measurement and Management of QT Interval Prolongation for General Physicians.
Indraratna P; Tardo D; Delves M; Szirt R; Ng B
J Gen Intern Med; 2020 Mar; 35(3):865-873. PubMed ID: 31654357
[TBL] [Abstract][Full Text] [Related]
24. [Torsades de pointes initiated by slow ventricular stimulation].
Fontaine G; Frank R; Lascault G; Tonet JL; Fillette F; Grosgogeat Y
Arch Mal Coeur Vaiss; 1983 Aug; 76(8):918-24. PubMed ID: 6414425
[TBL] [Abstract][Full Text] [Related]
25. Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias.
Takahara A; Sugiyama A; Ishida Y; Satoh Y; Wang K; Nakamura Y; Hashimoto K
Br J Pharmacol; 2006 Mar; 147(6):634-41. PubMed ID: 16314854
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, therapeutic response, and outcome of ventricular tachycardia in the out-of-hospital setting: a comparison of monomorphic ventricular tachycardia, polymorphic ventricular tachycardia, and torsades de pointes.
Brady WJ; DeBehnke DJ; Laundrie D
Acad Emerg Med; 1999 Jun; 6(6):609-17. PubMed ID: 10386678
[TBL] [Abstract][Full Text] [Related]
27. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.
Tisdale JE; Rasty S; Padhi ID; Sharma ND; Rosman H
J Clin Pharmacol; 2001 Dec; 41(12):1310-8. PubMed ID: 11762558
[TBL] [Abstract][Full Text] [Related]
28. Increased propensity of women to develop torsades de pointes during complete heart block.
Kawasaki R; Machado C; Reinoehl J; Fromm B; Baga JJ; Steinman RT; Lehmann MH
J Cardiovasc Electrophysiol; 1995 Nov; 6(11):1032-8. PubMed ID: 8589872
[TBL] [Abstract][Full Text] [Related]
29. Predictive factors of ventricular fibrillation triggered by pause-dependent torsades de pointes associated with acquired long QT interval: role of QT dispersion and left ventricular function.
Da Costa A; Chalvidan T; Belounas A; Messier M; Viallet M; Mansour H; Lamaison D; Djiane P; Isaaz K
J Cardiovasc Electrophysiol; 2000 Sep; 11(9):990-7. PubMed ID: 11021469
[TBL] [Abstract][Full Text] [Related]
30. Torsades de pointes and long QT syndromes.
Janeira LF
Am Fam Physician; 1995 Oct; 52(5):1447-53. PubMed ID: 7572567
[TBL] [Abstract][Full Text] [Related]
31. [Torsades de Pointes: a cause of syncope in sinus node dysfunction].
Velázquez Rodríguez E; Rangel Rojo J; Ortega Sánchez A; Zamudio Villafuerte A; González Gallardo S
Arch Inst Cardiol Mex; 1998; 68(6):498-505. PubMed ID: 10365226
[TBL] [Abstract][Full Text] [Related]
32. Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence.
Barrett TD; Hennan JK; Fischbach PS; O'Neill BP; Driscoll EM; Lucchesi BR
Br J Pharmacol; 2001 Apr; 132(7):1493-500. PubMed ID: 11264243
[TBL] [Abstract][Full Text] [Related]
33. Torsade de pointes associated with bradycardia and takotsubo cardiomyopathy.
Kurisu S; Inoue I; Kawagoe T; Ishihara M; Shimatani Y; Nakama Y; Ohkawa K; Maruhashi T; Kagawa E; Dai K; Aokage T
Can J Cardiol; 2008 Aug; 24(8):640-2. PubMed ID: 18685745
[TBL] [Abstract][Full Text] [Related]
34. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases.
Takahashi N; Ito M; Inoue T; Koumatsu K; Takeshita Y; Tsumabuki S; Tamura M; Inoue K; Maeda T; Saikawa T
J Cardiol; 1993; 23(1):99-106. PubMed ID: 8164140
[TBL] [Abstract][Full Text] [Related]
35. Relations of QTc prolongation on the electrocardiogram to torsades de pointes: definitions and mechanisms.
Morganroth J
Am J Cardiol; 1993 Aug; 72(6):10B-13B. PubMed ID: 8256748
[TBL] [Abstract][Full Text] [Related]
36. Adenosine induced torsades de pointes in a child with congenital long QT syndrome.
Celiker A; Tokel K; Cil E; Ozkutlu S; Ozme S
Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 1):1814-7. PubMed ID: 7838793
[TBL] [Abstract][Full Text] [Related]
37. Repolarization characteristics and incidence of Torsades de Pointes in patients with acquired complete atrioventricular block.
Bozkaya YT; Eroğlu Z; Kayikçioğlu M; Payzin S; Can LH; Kültürsay H; Hasdemir C
Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():98-100. PubMed ID: 17584695
[TBL] [Abstract][Full Text] [Related]
38. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome.
Drici MD; Clément N
Drug Saf; 2001; 24(8):575-85. PubMed ID: 11480490
[TBL] [Abstract][Full Text] [Related]
39. Preventing torsades de pointes by careful cardiac monitoring in hospital settings.
Sommargren CE; Drew BJ
AACN Adv Crit Care; 2007; 18(3):285-93. PubMed ID: 18019519
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of bepridil-induced intraoperative torsades de pointes by isoproterenol infusion.
Shimano K; Chang K; Hara Y; Yasuda A; Sawamura S
JA Clin Rep; 2021 Oct; 7(1):76. PubMed ID: 34643822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
